C12N2500/34

SELECTIVE MEDIUM COMPOSITION FOR DETECTION OF P. CAROTOVORUM AND DETECTION METHOD USING THE SAME

The present disclosure relates to a culture composition for detection of P. carotovorum, including pectin, cellobiose, and inositol as active ingredients. P. carotovorum is highly likely to cause soft rot during cultivation as well as storage and transportation such that continuous monitoring is required. In order to solve the issues, the medium composition ensures remarkably outstanding selectivity for P. carotovorum.

Systems and methods for the production of diphtheria toxin polypeptides

An expression system and process for the production of Diphtheria toxin polypeptides or mutated forms thereof, such as the toxoid CRM197 polypeptide, in genetically-modified E. coli with high yield is described. The system and process is based on the uncoupling of biomass growth from recombinant protein induction, i.e. using an inducer of protein production that cannot be used as a carbon source for growth by the bacteria. The use of specific components and conditions that improve protein yields are also described.

COMPOSITIONS AND METHODS FOR CULTURING HEMATOPOIETIC STEM AND PROGENITOR CELLS

The present disclosure provides compositions and methods for culturing hematopoietic stem and progenitor cells, while maintaining or increasing the subpopulation of hematopoietic stem cells (HSCs). The methods and compositions describe us a 3D zwitterionic hydrogel to provide a biocompatible culture microenvironment for culturing encapsulated hematopoietic stem and progenitor cells.

3D TISSUE COMPOSITE AND METHOD OF PRODUCING 3D TISSUE COMPOSITE

A method of producing a 3D tissue composite, comprising: a preparation step in which a multiple number of sheet-shaped first structures containing first cells are prepared, wherein at least one of the multiple number of first structures holds a second structure containing second cells; a stacking step in which the multiple number of first structures are stacked to form a 3D composite; and a culturing step in which the 3D composite is cultured to form a 3D tissue composite containing first tissues formed from the first cells and second tissues formed from the second cells.

SERPIN PRODUCTION

Use of galactose or a galactooligosaccharide, for increasing serpin protein production in Bifidobacterium longum subsp. longum.

IN VITRO EMBRYO RESCUE
20230217875 · 2023-07-13 ·

The present invention relates to the use of trehalose, and/or a derivative thereof, as a supplement to a culture medium for culturing hybrid plant embryos in in vitro embryo rescue. The addition of trehalose, and/or a derivative thereof, to the culture medium significantly increased the survival rate of the hybrid plant embryos.

Cell culture methods and media comprising N-acetylcysteine
11555175 · 2023-01-17 · ·

This application provides improved cell culture media and cell culture methods comprising N-acetylcysteine. These improved cell culture media and cell culture methods increase cell viability, cellular growth rate and/or reduce cell doubling time of cholesterol auxotrophic cells, myeloma cells, and hybridoma cells.

CELL CULTURE MEDIA

The present invention relates to cell culture media comprising N-lactoyl derivatives of one or more amino acid. The poor solubility of some amino acids in cell culture media is overcome by substituting them with an N-lactoyl derivative.

Compositions and methods for modifying cell surface glycans
11535831 · 2022-12-27 · ·

Methods and compositions for modifying glycans (e.g., glycans expressed on the surface of live cells or cell particles) are provided herein.

MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME

Among the various aspects of the present disclosure is the provision of a media for cryopreserved cells and methods of making and using same. An aspect of the present disclosure provides for a cell media formulation comprising (e.g., for day 0) one or more components selected from: MCDB 131; Glutamax; P/S; BSA; Glucose; ZnSO4; an enzyme for digesting DNA (e.g., DNASE1); and/or an apoptosis inhibitor (e.g., BI-6C9).